Company Overview and News

 
A Look at Mining Stocks’ Technicals

9h marketrealist
Recent market unrest has had a significant effect on precious metals and the US dollar, which influences dollar-denominated precious metals and mining stocks. In this part of the series, we’ll look at miners’ RSI (relative strength index) scores and implied volatility. The miners we’ve selected for our analysis are Wheaton Precious Metals (SLW), Randgold Resources (GOLD), AngloGold Ashanti (AU), and IAMGOLD (IAG).
Upvote Downvote

 
Will Currency Wars Move the US Dollar after Trade War Concerns?

2018-04-17 marketrealist
Yesterday, Donald Trump accused Russia and China of devaluing their currencies. Trump tweeted that China and Russia are playing “the currency devaluation game as the U.S. keeps raising interest rates. Not acceptable!” Investors should note that this is a contradiction of the US Treasury, which had maintained that no major trading partners are manipulating their currencies.
Upvote Downvote

 
Will Gold Take Cues from the Fed’s Decisions?

2018-04-17 marketrealist
Overall, gold has been rising in 2018, mainly due to the geopolitical tensions that keep increasing. First, we had fears of a US-China trade war, and now we have the Syrian chemical attack and subsequent air strikes. Another crucial element is the decline of the US dollar, which we’ll look at in the next part of this series.
Upvote Downvote

 
How Miners Are Performing

2018-04-10 marketrealist
Usually, precious metal mining companies follow precious metals. Gold, platinum, and palladium had an up-day on Monday, April 9. Though the mining companies tend to closely react to miners, they showed a mixed performance on Monday.
Upvote Downvote

 
Top Dividend Raises And Cuts For March 2018

2018-04-09 seekingalpha
Dividend growth investing is a popular model followed by the investing community to build assets. Companies which not only pay dividends, but raise them year after year have been shown to perform better overall for investor returns.
Upvote Downvote

 
How Mining Companies Are Performing Compared to Precious Metals

2018-04-06 editors.aws.marketrealist
Mining companies gave mixed reactions on Wednesday, April 4, 2018. Gold rose, while the other three precious metals traded lower. Most of the time, miners follow the price movements of precious metals, but sometimes they are affected by company-specific and other market factors.
Upvote Downvote

 
Trump's Tweets Are Hurting The Markets - Cramer's Mad Money (4/5/18)

2018-04-06 seekingalpha
The volatile nature of the market has got Cramer worried. It's not going to be smooth sailing, as there are new risks affecting the market's rally.
Upvote Downvote

 
Market report: Shire shored up by suitor’s confidence

2018-04-06 telegraph.co.uk
Deal-hungry traders lifted pharma takeover target Shire to a fresh three-month high after Japanese suitor Takeda laid the groundwork for a bid.
Upvote Downvote

 
Resolute to acquire 27% of Loncor as part of African expansion

2018-04-05 australianmining.com.au
Resolute Mining has secured a binding agreement to acquire 27 per cent of Canadian exploration company Loncor Resources, known for its gold prospects in the Democratic Republic of Congo (DRC).
Upvote Downvote

 
BlackRock's $1.3 Billion Gold Fund Feels Pain of Miners - Bloomberg

2018-04-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Factors that Could Pressure the US Dollar and Benefit Gold

2018-04-03 editors.aws.marketrealist
Gold’s recent gains came on the back of uncertainty, which was pinned by weakness in the US dollar (UUP). The dollar is down ~2.5% year-to-date, as the majority of the recent events were negative for the dollar. The Fed’s less-hawkish-than-expected guidance in the near term, trade war talks, recent inflation, and other economic data were mostly negative for the dollar.
Upvote Downvote

 
The Return of Volatility: Good News for Gold Investors

2018-04-03 editors.aws.marketrealist
On March 23, 2018, gold futures hit a two-year high. Gold spot prices also rose 3.3% in the week ended March 23—the largest weekly gain since April 2016. The most recent spike in gold prices came after President Trump announced that the US government is considering import tariffs on $60.0 billion in imports from China. China also warned of $3.0 billion in retaliatory tariffs.
Upvote Downvote

 
Randgold Resources - GOLD - Drive to resolve industrial action at Tongon

2018-04-03 accesswire
ABIDJAN, COTE D IVOIRE / ACCESSWIRE / April 3, 2018 / Randgold Resources said today intermittent industrial action by the workforce of its mining subcontractor was having some impact on operations at its Tongon gold mine.
Upvote Downvote

 
Show of state power testing miners’ mettle

2018-03-31 telegraph.co.uk
From the far corners of the globe they came: some of the world’s most powerful mining bosses, summoned to a dull conference room in Kinshasa to plead their case before the president of the Democratic Republic of the Congo.
Upvote Downvote

 
Randgold Resources - GOLD - Mining code proposal submitted to DRC government

2018-03-29 accesswire
KINSHASA, DRC / ACCESSWIRE / March 29, 2018 / Mining industry representatives* in the Democratic Republic of Congo have submitted a formal proposal to the country's Ministry of Mines that is designed to address concerns about the recently revised mining code as well as the government's revenue needs.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...